STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

75 hedge funds and large institutions have $119M invested in Stemline Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 20 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.41M
Puts
$1.18M
Net Calls
Net Calls Change

Top Buyers

1 +$10.4M
2 +$9.09M
3 +$7.78M
4
Axa
Axa
France
+$3.71M
5
IBT
International Biotechnology Trust
United Kingdom
+$2.81M

Top Sellers

1 -$2.61M
2 -$1.81M
3 -$1.01M
4
VMI
VHCP Management II
New York
-$751K
5
Renaissance Technologies
Renaissance Technologies
New York
-$701K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$21.7M
2
$12.4M
3
$10.4M
4
$9.98M
5
$9.29M
6
$7.05M
7
$5.42M
8
$3.71M
9
$3.66M
10
$2.81M
11
$2.65M
12
$2.56M
13
$2.48M
14
$1.99M
15
$1.95M
16
$1.92M
17
$1.84M
18
$1.37M
19
$1.2M
20
$1.19M
21
$1.02M
22
$855K
23
$840K
24
$745K
25
$657K